Events

The 3rd Bacteriophage Therapy Summit returns! With a new looking speaker line-up and never before seen content, we are excited to continue to unite the community to progress fundamental bacteriophage research into clinically-significant products. The overuse of antibiotics had led to the development of multi-resistant bacterial strains, most notably ESKAPE pathogens, rendering the use of […]

The ASID Annual Scientific Meeting is the leading Australasian meeting for adult and paediatric infectious disease and clinical microbiology specialists. The conference is an ideal opportunity for connecting clinicians, microbiologists and other health professions with a common interest in infectious diseases and provides a friendly forum for the exchange of scientific advances in the prevention, […]

Please join us on Thursday, March 25th, at noon for this month’s Levy CIMAR Science Meeting on “Innovation Solutions to AMR.” We are excited to hear from Kevin Outterson, Esq., Professor of Law at Boston University and Executive Director of the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, or CARB-X. CARB-X is a global partnership hosted […]

We are excited to announce ‘Decennial Day’ which will be a complimentary program to SHEA Spring 2021. Decennial Day will feature a few selected sessions from the 2020 Decennial Program to be virtually held on April 12, 2021. More information to come on sessions and speakers at a later date. You will automatically be registered […]

Who should come to SHEA Spring 2021? SHEA members and non-members of all disciplines relating to Infection Prevention Programs, Antibiotic Stewardship Programs, Public Health, Pharmacy, Occupational Health, Clinical Microbiology, Quality Improvement, and Patient Safety. If you are involved in infection prevention or infection control you need to be at SHEA Spring 2021! Click here to learn more. […]

Infectious diseases are one of the largest threats to global public health. The focus on the threat has never been greater, with the COVID-19 pandemic demonstrating the critical need for a more proactive approach within governments, biopharma, and investment communities to overcome the pressing issues in anti-infective drug development to combat antimicrobial resistance. With some now considering […]

As AMR emerges, new strategies for the treatment of infection and identification of resistant microbes are crucial. This JPIAMR activity, led by the UK Medical Research Council (MRC) with support from South Africa (SAMRC), Korea (NRF), France (ANR), and Canada (CIHR) is delivered as part of JPIAMR’s mission to enable global coordination of research. The […]

Infectious diseases are one of the largest threats to global public health. The focus on the threat has never been greater, with the COVID-19 pandemic demonstrating the critical need for a more proactive approach within governments, biopharma, and investment communities to overcome the pressing issues in anti-infective drug development to combat antimicrobial resistance. With some […]

FDA, NIAID and CDC are announcing a public workshop regarding the development considerations of antimicrobial drugs for the treatment of gonorrhea. The workshop will focus on the current state and nonclinical and clinical trial design considerations regarding antimicrobial drug development for gonorrhea and include the following topic areas: Animal models Clinical pharmacology considerations Trial design […]

This course is designed to increase the knowledge of managing patients with CF across the lifespan of all who interact with this population. About this Event The target audience includes nurses, respiratory therapists, physical and occupational therapists, social workers, dieticians, child life specialists, and physicians Click here to learn more and register.